Copyright
©The Author(s) 2004.
World J Gastroenterol. Aug 1, 2004; 10(15): 2190-2194
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2190
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2190
Table 2 Determination of serum hIL-2 or mIL-12 3 d after administration of IL gene (ng/mL)
| Group | HIL-2 | MIL-12 |
| Physiologic saline control | < 0.8 | < 0.8 |
| Blank vector control | < 0.8 | < 0.8 |
| IL-2 gene therapy | 19.4 ± 1.8 | < 0.8 |
| IL-12 gene therapy | < 0.8 | 22 ± 2.5 |
| IL-12-IL-2fused gene therapy | 18.5 ± 2.4 | 20.5 ± 2.5 |
- Citation: You TG, Wang HS, Yang JH, Qian QJ, Fan RF, Wu MC. Transfection of IL-2 and/or IL-12 genes into spleen in treatment of rat liver cancer. World J Gastroenterol 2004; 10(15): 2190-2194
- URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2190.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2190